Guo Shuning, Li Jiehan, Pang Shurui, Li Jing, Tian Xinping
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China.
Arthritis Res Ther. 2025 Jan 20;27(1):11. doi: 10.1186/s13075-025-03475-1.
Advances in treatment have swiftly alleviated systemic inflammation of Takayasu's arteritis (TAK), while subclinical vascular inflammation and the ensuing arterial remodeling continue to present unresolved challenges in TAK. The phenotypic switching of vascular smooth muscle cells (VSMC) is regarded as the first step in vascular pathology and contributes to arterial remodeling. Exosomes facilitate the transfer and exchange of proteins and specific nucleic acids, thereby playing a significant role in intercellular communication. Little is known about the modulatory role of serum exosomes in phenotypic switching of VSMC and vascular remodeling in TAK.
Serum exosomes isolated from TAK patients were co-cultured with VSMC to identify the modulatory role of exosomes. VSMC were transfected with miR-199a-5p mimic and inhibitor. CCK8 assays and EdU assays were performed to measure proliferative ability. The migration of VSMC was evaluated by scratch assays and transwell migration assays. The flow cytometry was employed to identify apoptosis of VSMC. Dual-luciferase reporter assay, RNA immunoprecipitation assay and fluorescence in situ hybridization were utilized to validate the target gene of miR-199a-5p. The correlational analysis was conducted among exosome miRNA, serum MMP2, TIMP2 and clinical parameters in TAK patients.
The coculture of VSMC with serum exosome mediated dedifferentiation of VSMC. Through gain- and loss-of-function approaches, miR-199a-5p over-expression significantly increased expression of VSMC marker genes and inhibited VSMC proliferation and migration, whilst the opposite effect was observed when endogenous miR-199a-5p was knocked down. The overexpression of miR-199a-5p suppressed VSMC apoptosis. Further, MMP2 serves as functional target gene of miR-199a-5p. The correlation analyses revealed an inverse correlation between Vasculitis Damage Index and exosome miR-199a-5p level or serum MMP2, which requires validation in a larger cohort.
Our study indicated that the miR-199a-5p/MMP2 pathway played a role in inhibiting the migration, proliferation and apoptosis of VSMC. The decreased secretion of MMP2 may potentially prompt the intimal infiltration of inflammatory cells within the vascular wall, offering a novel therapeutic opportunity by tackling both inflammatory responses and the neointimal overgrowth associated with TAK arterial damage. Moreover, exosome miR-199a-5p and MMP2 derived from serum possess potential as future biomarkers for vascular injury.
治疗方法的进步已迅速缓解了大动脉炎(TAK)的全身炎症,而亚临床血管炎症及随之而来的动脉重塑仍是TAK中尚未解决的挑战。血管平滑肌细胞(VSMC)的表型转换被视为血管病变的第一步,并促成动脉重塑。外泌体促进蛋白质和特定核酸的传递与交换,从而在细胞间通讯中发挥重要作用。关于血清外泌体在TAK中VSMC表型转换和血管重塑中的调节作用知之甚少。
将从TAK患者中分离出的血清外泌体与VSMC共培养,以确定外泌体的调节作用。用miR-199a-5p模拟物和抑制剂转染VSMC。进行CCK8测定和EdU测定以测量增殖能力。通过划痕试验和Transwell迁移试验评估VSMC的迁移。采用流式细胞术鉴定VSMC的凋亡。利用双荧光素酶报告基因测定、RNA免疫沉淀测定和荧光原位杂交来验证miR-199a-5p的靶基因。对TAK患者的外泌体miRNA、血清MMP2、TIMP2和临床参数进行相关性分析。
VSMC与血清外泌体共培养介导了VSMC的去分化。通过功能获得和功能丧失方法,miR-199a-5p过表达显著增加了VSMC标记基因的表达,并抑制了VSMC的增殖和迁移,而当内源性miR-199a-5p被敲低时则观察到相反的效果。miR-199a-5p的过表达抑制了VSMC凋亡。此外,MMP2是miR-199a-5p的功能靶基因。相关性分析显示血管炎损伤指数与外泌体miR-199a-5p水平或血清MMP2之间呈负相关,这需要在更大的队列中进行验证。
我们的研究表明,miR-199a-5p/MMP2途径在抑制VSMC的迁移、增殖和凋亡中发挥作用。MMP2分泌减少可能会促使血管壁内炎症细胞的内膜浸润,通过解决炎症反应和与TAK动脉损伤相关的新生内膜过度生长提供了一个新的治疗机会。此外,血清来源的外泌体miR-199a-5p和MMP2具有作为未来血管损伤生物标志物的潜力。